Literature DB >> 10778924

Determination of mandelic acid enantiomers in urine by gas chromatography and electron-capture or flame ionisation detection.

S Kezić1, I Jakasa, M Wenker.   

Abstract

A sensitive and stereospecific GC method was developed for the analysis of R- and S-enantiomers of mandelic acid (MA) in urine, using a chiral CP Chirasil-Dex-CB column. The enantiomers of MA were derivatised with isopropanol into their corresponding isopropyl esters and determined either directly with flame ionisation detection (FID) or after subsequent derivatisation of a hydroxy group with pentafluoropropionic anhydride with electron-capture detection (ECD). Both derivatisation steps proceeded with negligible inversion of enantiomers (<1%). The limit of detection of the FID determination was 8 and 5 mg/l for R-MA and S-MA, respectively and of the ECD determination 1 mg/l for both enantiomers. Repeatability (within-day precision) and reproducibility (day-to-day precision) was for both enantiomers below 7.5% for the FID and below 5.8% for the ECD analysis. The method was applied to urine of volunteers exposed to 105 and 420 mg styrene/m3 air. In the urine of the exposed volunteers, the S-enantiomer showed higher excretion compared to that of the R-enantiomer, with marked interindividual differences in excretion of both enantiomers.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10778924     DOI: 10.1016/s0378-4347(99)00500-9

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  2 in total

1.  Development and Validation of a Reversed-phase HPLC Method for the Determination of Hydroxybenzene in a Cream Formulation.

Authors:  G A Shabir
Journal:  Indian J Pharm Sci       Date:  2010-05       Impact factor: 0.975

2.  Chiral hydroxylation at the mononuclear nonheme Fe(II) center of 4-(S) hydroxymandelate synthase--a structure-activity relationship analysis.

Authors:  Cristiana M L Di Giuro; Cornelia Konstantinovics; Uwe Rinner; Christina Nowikow; Erich Leitner; Grit D Straganz
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.